CIR
IONS icon

Clear Investment Research’s Ionis Pharmaceuticals IONS Stock Holding History

Clear Investment Research’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71
Closed -$5.33K – 122
2026
Q1 		$5.33K Buy
+71
New +$5.6K 0.01% 179
2025
Q4 		– Sell
-71
Closed -$4.64K – 130
2025
Q3 		$4.64K Hold
71
– – 0.01% 198
2025
Q2 		$2.81K Buy
71
+20
+39% +$655 ﹤0.01% 188
2025
Q1 		$1.78K Hold
51
– – ﹤0.01% 194
2024
Q4 		$1.78K Hold
51
– – ﹤0.01% 193
2024
Q3 		$2.04K Buy
+51
New +$2.37K ﹤0.01% 191

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Clear Investment Research's IONS Position: Q2 2026 in Review

Clear Investment Research sold out of Ionis Pharmaceuticals (IONS) in Q2 2026, closing a stake of 71 shares — an estimated $5.33K sold.

Clear Investment Research first reported a position in IONS in Q3 2024 and held it in 6 quarters. The position peaked at $5.33K in Q1 2026. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Clear Investment Research reported no remaining Ionis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Clear Investment Research sold 71 Ionis Pharmaceuticals shares in Q2 2026, an estimated $5.33K.
  • Clear Investment Research first reported a position in Ionis Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Clear Investment Research's Ionis Pharmaceuticals position peaked at $5.33K in Q1 2026.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Clear Investment Research's 13F filing for Q2 2026, filed 11 Aug 2026.